Diwa, Aizarah .
HRN: 22-61-06 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2026
CEFUROXIME 1.5GM (VIAL)
01/10/2026
01/11/2026
IV
1.5g
Q8
S/p CS
Checking Initial Appropriateness
01/10/2026
CEFUROXIME 500MG (TAB)
01/11/2026
01/18/2026
PO
500mg
BID
S/p
Checking Initial Appropriateness